Skip to main content

Overriding sorafenib resistance via blocking lipid metabolism and Ras by sphingomyelin synthase 1 inhibition in hepatocellular carcinoma.

Lu H, Zhou L, Zuo H, Le W, Hu J, Zhang T, Li M, Yuan Y
Cancer Chemother Pharmacol. 2021 Feb;87(2):217-228. doi: 10.1007/s00280-020-04199-6. Epub 2020 Nov 23. (Link opens in a new window) PubMed (Link opens in a new window) Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.

Antibodies from Article